Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.

[1]  Ronald M Peshock,et al.  The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. , 2004, The American journal of cardiology.

[2]  P. Kirkham,et al.  Cigarette smoke triggers macrophage adhesion and activation: role of lipid peroxidation products and scavenger receptor. , 2003, Free radical biology & medicine.

[3]  M. Serrano-Martínez,et al.  Monocyte chemoattractant protein-1 concentration in coronary sinus blood and severity of coronary disease. , 2003, Circulation.

[4]  E. Antman,et al.  Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes , 2003, Circulation.

[5]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[6]  Michael R. Müller,et al.  Simvastatin Reduces Expression of Cytokines Interleukin-6, Interleukin-8, and Monocyte Chemoattractant Protein-1 in Circulating Monocytes From Hypercholesterolemic Patients , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[7]  A. Hofman,et al.  The association between coronary calcification assessed by electron beam computed tomography and measures of extracoronary atherosclerosis: the Rotterdam Coronary Calcification Study. , 2002, Journal of the American College of Cardiology.

[8]  L. Badimón,et al.  HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels. , 2001, Atherosclerosis.

[9]  C. Stefanadis,et al.  Chemokines in patients with ischaemic heart disease and the effect of coronary angioplasty. , 2001, International journal of cardiology.

[10]  J. Haginaka,et al.  Oxidants in cigarette smoke extract modify low-density lipoprotein in the plasma and facilitate atherogenesis in the aorta of Watanabe heritable hyperlipidemic rabbits. , 2001, Atherosclerosis.

[11]  M. Reale,et al.  Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[12]  A. Mantovani,et al.  Inhibition of Monocyte Chemotactic Protein-1 Synthesis by Statins , 2000, Laboratory Investigation.

[13]  J. Joven,et al.  The value of apolipoprotein E knockout mice for studying the effects of dietary fat and cholesterol on atherogenesis. , 2000, Current opinion in lipidology.

[14]  Y. Ouchi,et al.  Increase in circulating levels of monocyte chemoattractant protein-1 with aging. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[15]  N. Maeda,et al.  Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. , 1999, Atherosclerosis.

[16]  J. Kelley,et al.  Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[17]  J. Egido,et al.  ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis. , 1998, The American journal of pathology.

[18]  O. Quehenberger,et al.  Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[19]  J. Egido,et al.  HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. , 1998, Journal of the American College of Cardiology.

[20]  K. Kugiyama,et al.  Simultaneous elevation of the levels of circulating monocyte chemoattractant protein-1 and tissue factor in acute coronary syndromes. , 1998, Japanese circulation journal.

[21]  P. Libby,et al.  Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.

[22]  B. Rollins,et al.  Tissue Factor Is Induced by Monocyte Chemoattractant Protein-1 in Human Aortic Smooth Muscle and THP-1 Cells* , 1997, The Journal of Biological Chemistry.

[23]  J. Egido,et al.  Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. , 1997, Circulation.

[24]  A. Siegbahn,et al.  Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor. , 1996, Thrombosis research.

[25]  P. Libby.  Molecular bases of the acute coronary syndromes. , 1995, Circulation.

[26]  V. Fuster,et al.  Macrophage Infiltration in Acute Coronary Syndromes: Implications for Plaque Rupture , 1994, Circulation.

[27]  J. Qiao,et al.  Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. , 1994, The Journal of clinical investigation.

[28]  R. Detrano,et al.  Detection of coronary artery calcium by ultrafast computed tomography and its relation to clinical evidence of coronary artery disease. , 1994, The American journal of cardiology.

[29]  W. Janowitz,et al.  Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women. , 1993, The American journal of cardiology.

[30]  E. Leonard,et al.  Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. , 1993, Human pathology.

[31]  J. Tobis,et al.  Risk factor correlates of coronary calcium as evaluated by ultrafast computed tomography. , 1992, American Journal of Cardiology.

[32]  D. Harman.  Free radical theory of aging. , 1992, Triangle; the Sandoz journal of medical science.

[33]  A. J. Valente,et al.  Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Detrano,et al.  Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.

[35]  J. Kisslo,et al.  The diagnostic and prognostic significance of coronary artery calcification. A report of 800 cases. , 1980, Radiology.

[36]  E. Zajac,et al.  Influence of age and gender on the presence of coronary calcium detected by ultrafast computed tomography. , 1995, Journal of the American College of Cardiology.